On Invalid Date, Equillium (NASDAQ: EQ) reported Q2 2024 earnings per share (EPS) of $0.01, up 110% year over year. Total Equillium earnings for the quarter were $468.00 thousand. In the same quarter last year, Equillium's earnings per share (EPS) was -$0.10.
As of Q3 2024, Equillium's earnings has grown year over year. Equillium's earnings in the past year totalled -$8.32 million.
What was EQ's revenue last quarter?
On Invalid Date, Equillium (NASDAQ: EQ) reported Q2 2024 revenue of $13.85 million up 51.83% year over year. In the same quarter last year, Equillium's revenue was $9.12 million.
What was EQ's revenue growth in the past year?
As of Q3 2024, Equillium's revenue has grown 26.25% year over year. This is 50.64 percentage points lower than the US Biotechnology industry revenue growth rate of 76.88%. Equillium's revenue in the past year totalled $42.62 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.